The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs
Open accessAbstract
Nicotine dependence is one of the world's leading causes of preventable death. To discover genetic variants that influence risk for nicotine dependence, we targeted over 300 candidate genes and analyzed 3713 single nucleotide polymorphisms (SNPs) in 1050 cases and 879 controls. The Fagerström test for nicotine dependence (FTND) was used to assess dependence, in which cases were required to have an FTND of 4 or more. The control criterion was strict: control subjects must have smoked at least 100 cigarettes in their lifetimes and had an FTND of 0 during the heaviest period of smoking. After correcting for multiple testing by controlling the false discovery rate, several cholinergic nicotinic receptor genes dominated the top signals. The strongest association was from an SNP representing CHRNB3, the beta3 nicotinic receptor subunit gene (P = 9.4 x 10(-5)). Biologically, the most compelling evidence for a risk variant came from a non-synonymous SNP in the alpha5 nicotinic receptor subunit gene CHRNA5 (P = 6.4 x 10(-4)). This SNP exhibited evidence of a recessive mode of inheritance, resulting in individuals having a 2-fold increase in risk of developing nicotine dependence once exposed to cigarette smoking. Other genes among the top signals were KCNJ6 and GABRA4. This study represents one of the most powerful and extensive studies of nicotine dependence to date and has found novel risk loci that require confirmation by replication studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It has been shown that allelic variation in the α5/α3/β4 nAChR subunit gene cluster located in chromosome region 15q25 significantly increases risk of tobacco addiction (Saccone et al. 2007;Berrettini et al. 2008;Lips et al. 2010).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Saccone et al. 2007
In the citing paper
“The most compelling evidence for risk variants contributing to smoking behavior was in the CHRNA5/A3/B4 gene cluster, which encodes the α5, α3, and β4 subunits.”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [91]
In the citing paper
“The most thoroughly investigated and replicated finding to date is the association with rs16969968, in CHRNA5 (91).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [91]
In the citing paper
“A second signal in the CHRNA5/A3/B4 cluster is tagged by SNP rs578776; it is strongly associated with nicotine dependence and has a low correlation with rs16969968 (r2 = 0.18), indicating that it represents a statistically independent signal (90,91).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [91]
In the citing paper
“With regard to the latter factors, initiation of smoking behavior and transition to dependence (i.e. persistent smoking) has been found to show strong heritability (60). The reported heritability coefficients range from 30% to greater than 80% (a mean of approximately 60% for initiation and 70% for progression to dependence).”
From Tobacco addiction (2008) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Inference of Population Structure Using Multilocus Genotype Data
Pritchard, J. K., Stephens, M., & Donnelly, P. (2000) · Genetics · doi:10.1093/genetics/155.2.945 · Cited by 33,871
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,563
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
A Direct Approach to False Discovery Rates
Storey, J. D. (2002) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00346 · Cited by 5,603
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
Carlson, C. S., Eberle, M. A., Rieder, M. J., Qian, Y., Kruglyak, L., & Nickerson, D. A. (2004) · The American Journal of Human Genetics · doi:10.1086/381000 · Cited by 1,587
Tanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413
Mackay, J. M., & Eriksen, M. P. (2002) · Medical Entomology and Zoology · Cited by 1,322
Research works printed but not linked: 1
- Tapper, 2006, Neuronal nicotinic acetylcholine receptors and nicotine dependence
Cited by
Sorted by citations
Items 201–300 of 851
Genome-wide association study on the FEV1/FVC ratio in never-smokers identifies HHIP and FAM13A
van der Plaat, D. A., de Jong, K., Lahousse, L., Faiz, A., Vonk, J. M., van Diemen, C. C., Nedeljkovic, I., Amin, N., Brusselle, G., Albert Hofman, D., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.062 · Cited by 57
Nicotine Enhances Excitability of Medial Habenular Neurons via Facilitation of Neurokinin Signaling
Dao, D. Q., Perez, E. E., Teng, Y., Dani, J. A., & De Biasi, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2736-13.2014 · Cited by 56
Agrawal, A., Pergadia, M. L., Saccone, S. F., Hinrichs, A. L., Lessov‐Schlaggar, C. N., Saccone, N. L., Neuman, R. J., Breslau, N., Johnson, E., Hatsukami, D., et al. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02236.x · Cited by 56
Self-citationBae, E. Y., Lee, S. Y., Kang, B. K., Lee, E. J., Choi, Y. Y., Kang, H., Choi, J. E., Jeon, H.-S., Lee, W. K., KAM, S., et al. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02165.x · Cited by 55
Mendelian Randomization: Application to Cardiovascular Disease
Timpson, N. J., Wade, K. H., & Smith, G. D. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0242-7 · Cited by 60
Genome Wide Association for Addiction: Replicated Results and Comparisons of Two Analytic Approaches
Drgon, T., Zhang, P.-W., Johnson, C., Walther, D. M., Hess, J., Nino, M., & Uhl, G. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008832 · Cited by 57
Substance‐related and addictive disorders
Crowley, T. J., & Sakai, J. T. (2015) · Wiley eBooks · doi:10.1002/9781118381953.ch66 · Cited by 56
Lind, P. A., Macgregor, S., Agrawal, A., Montgomery, G. W., Heath, A. C., Martin, N. G., & Whitfield, J. B. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00768.x · Cited by 55
Self-citationNicotinic acetylcholine receptors: upregulation, age‐related effects and associations with drug use
Melroy-Greif, W. E., Stitzel, J. A., & Ehringer, M. A. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12251 · Cited by 58
Hoft, N. R., Corley, R. P., McQueen, M. B., Huizinga, D. H., Menard, S., & Ehringer, M. A. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00495.x · Cited by 56
Prentice, R. L., Huang, Y., Hinds, D. A., Peters, U., Pettinger, M. B., Cox, D., Beilharz, E. J., Chlebowski, R. T., Rossouw, J. E., Caan, B. J., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0611 · Cited by 56
Self-citationJanes, A. C., Smoller, J. W., David, S. P., Frederick, B. B., Haddad, S. A., Basu, A., D, M. F. M., Evins, A. E., & Kaufman, M. J. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.06.009 · Cited by 57
Validity of Recall of Tobacco Use in Two Prospective Cohorts
Brigham, J., Lessov‐Schlaggar, C. N., Javitz, H. S., Krasnow, R. E., Tildesley, E. A., Andrews, J. A., Hops, H., Cornelius, M. D., Day, N. L., McElroy, M., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq179 · Cited by 56
Self-citationLinkage-Disequilibrium-Based Binning Affects the Interpretation of GWASs
Christoforou, A., Dondrup, M., Mattingsdal, M., Mattheisen, M., Giddaluru, S., Nöthen, M. M., Rietschel, M., Cichon, S., Djurovic, S., Andreassen, O. A., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.02.025 · Cited by 57
Association of candidate genes with antisocial drug dependence in adolescents
Corley, R. P., Zeiger, J. S., Crowley, T. J., Ehringer, M. A., Hewitt, J. K., Hopfer, C. J., Lessem, J. M., McQueen, M. B., Rhee, S. H., Smolen, A., et al. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.02.004 · Cited by 52
BREITLING, L. P., Dahmen, N., Mittelstraß, K., Rujescu, D., Gallinat, J., Fehr, C., Giegling, I., Lamina, C., Illig, T., Müller, H., et al. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.6 · Cited by 55
The nicotinic cholinergic system function in the human brain
Nees, F. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.021 · Cited by 57
Pharmacogenetics of Nicotine Addiction: Role of Dopamine
Herman, A. I., DeVito, E. E., Jensen, K. P., & Sofuoglu, M. (2014) · Pharmacogenomics · doi:10.2217/pgs.13.246 · Cited by 59
Neurophysiology of Nicotine Addiction
Dani, J. A., Jenson, D., & Broussard, J. I. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-001 · Cited by 56
Sherva, R., Rice, J. P., Neuman, R. J., Rochberg, N., Saccone, N. L., & Bierut, L. J. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00904.x · Cited by 51
Self-citationMiwa, J. M., Lester, H. A., & Walz, A. (2012) · Physiology · doi:10.1152/physiol.00002.2012 · Cited by 52
Crucial role of nicotinic α5 subunit variants for Ca2+fluxes in ventral midbrain neurons
Sciaccaluga, M., Moriconi, C., Martinello, K., Catalano, M., Bermúdez, I., Stitzel, J. A., Maskos, U., & Fucile, S. (2015) · The FASEB Journal · doi:10.1096/fj.14-268102 · Cited by 54
Yan, J., Alıev, F., Webb, B. T., Kendler, K. S., Williamson, V. S., Edenberg, H. J., Arpana Agrawal, A., Kos, M. Z., Almasy, L. A., Nürnberger, J. I., et al. (2013) · Addiction Biology · doi:10.1111/adb.12035 · Cited by 52
Self-citationBehavioral and Genetic Evidence for GIRK Channels in the CNS
Mayfield, J., Blednov, Y. A., & Harris, R. A. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.05.016 · Cited by 54
Schnoll, R. A., Johnson, T. A., & Lerman, C. E. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0045-3 · Cited by 55
Personality in cross-cultural perspective
Dragūns, J. G. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596544.035 · Cited by 51
MicroRNA Regulators of Anxiety and Metabolic Disorders
Meydan, C., Shenhar‐Tsarfaty, S., & Soreq, H. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.07.001 · Cited by 52
Dopamine Genes and Nicotine Dependence in Treatment-Seeking and Community Smokers
Bergen, A. W., Conti, D. V., Berg, D. V. D., Lee, W., Liu, J., Li, D., Guo, N., Mi, H., Thomas, P. D., Lessov‐Schlaggar, C. N., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.52 · Cited by 50
Self-citationKim, W. J., Wood, A. M., Barker, A. F., Brantly, M., Campbell, E. J., Eden, E., McElvaney, N. G., Rennard, S. I., Sandhaus, R. A., Stocks, J. M., et al. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-16 · Cited by 48
REVIEW: Cognitive effects of nicotine: genetic moderators
Herman, A. I., & Sofuoglu, M. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00213.x · Cited by 52
Ruyck, K. D., Nackaerts, K., Beels, L., Werbrouck, J., Volder, A. D., Meysman, M., Salhi, B., van Meerbeeck, J. P., & Thierens, H. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.75 · Cited by 50
Inhibition of Nonneuronal α7-Nicotinic Receptor for Lung Cancer Treatment
Paleari, L., Negri, E., Catassi, A., Cilli, M., Servent, D., D’Angelillo, R. M., Cesario, A., Russo, P., & Fini, M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200806-908oc · Cited by 49
RetractedErsland, K. M., Christoforou, A., Stansberg, C. T., Espeseth, T., Mattheisen, M., Mattingsdal, M., Hardarson, G. A., Hansen, T. F., Fernandes, C. P. D., Giddaluru, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031687 · Cited by 49
George, A. A., Bloy, A., Miwa, J. M., Lindstrom, J. M., Lukas, R. J., & Whiteaker, P. (2017) · The FASEB Journal · doi:10.1096/fj.201600733r · Cited by 48
Relationship of common variants in CHRNA5 with early-onset schizophrenia and executive function
Han, W., Zhang, T., Ni, T., Zhu, L., Liu, D., Chen, G., Lin, H., Chen, T., & Guan, F. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.10.011 · Cited by 49
Mroziewicz, M., & Tyndale, R. F. (2010) · PubMed Central · Cited by 47
Glaaser, I. W., & Slesinger, P. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-04681-x · Cited by 48
Nicotine and alcohol: the role of midbrain dopaminergic neurons in drug reinforcement
Morel, C., Montgomery, S. E., & Han, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14160 · Cited by 50
Olfson, E., Saccone, N. L., Johnson, E. O., Chen, L.-S., Culverhouse, R., Doheny, K., Foltz, S. M., Fox, L., Gogarten, S. M., Hartz, S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.105 · Cited by 43
Self-citationChen, X., Feng, Y., Quinn, R. J., Pountney, D. L., Richardson, D. R., Mellick, G. D., & Ma, L. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000743 · Cited by 44
Gabrielsen, M. E., Romundstad, P., Langhammer, A., Krokan, H. E., & Skorpen, F. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.26 · Cited by 46
Dissection of the Phenotypic and Genotypic Associations With Nicotinic Dependence
Chen, L., Baker, T. B., Grucza, R. A., Wang, J. C. C., Johnson, E. O., Breslau, N., Hatsukami, D. K., Smith, S. S., Saccone, N. L., Saccone, S. F., et al. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr231 · Cited by 45
Self-citationA Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction
Bell, R. L., Hauser, S. R., Rodd, Z. A., Liang, T., Sari, Y., McClintick, J. N., Rahman, S., & Engleman, E. A. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.02.017 · Cited by 46
Nicotinic-nAChR signaling mediates drug resistance in lung cancer
Cheng, W., Chen, K.-Y., Lee, K., Feng, P., & Wu, S. (2019) · Journal of Cancer · doi:10.7150/jca.36359 · Cited by 46
Etter, J., Hoda, J., Perroud, N. A., Munafo, M. R., Burési, C., Duret, C., Neidhart, E., Malafosse, A., & Bertrand, D. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.05.010 · Cited by 48
Nishizawa, D., Fukuda, K., Kasai, S., Ogai, Y., Hasegawa, J., Sato, N., Yamada, H., Tanioka, F., Sugimura, H., Hayashida, M., et al. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14189fp · Cited by 45
Ray, R., Mitra, N., Baldwin, D. A., Guo, M., Patterson, F., Heitjan, D. F., Jepson, C., Wileyto, E. P., Wei, J., Payne, T. J., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.7 · Cited by 43
Identification of pharmacogenetic markers in smoking cessation therapy
Heitjan, D. F., Guo, M., Ray, R., Wileyto, E. P., Epstein, L. H., & Lerman, C. E. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30669 · Cited by 44
Comparison of Pathway Analysis Approaches Using Lung Cancer GWAS Data Sets
Fehringer, G., Liu, G., Briollais, L., Brennan, P., Amos, C. I., Spitz, M. R., Bickeböller, H., Wichmann, H. ‐., Risch, A., & Hung, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031816 · Cited by 45
Pharmacogenetics of Drug Dependence: Role of Gene Variations in Susceptibility and Treatment
Khokhar, J. Y., Ferguson, C. S., Zhu, A. Z. X., & Tyndale, R. F. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105826 · Cited by 44
Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries
Baurley, J. W., Edlund, C. K., Pardamean, C. I., Conti, D. V., Krasnow, R. E., Javitz, H. S., Hops, H., Swan, G. E., Benowitz, N. L., & Bergen, A. W. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw117 · Cited by 44
Self-citationThe Role of Nicotine in Schizophrenia
Featherstone, R. E., & Siegel, S. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.07.002 · Cited by 47
Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer
Santoro, A., Tomino, C., Prinzi, G., Lamonaca, P., Cardaci, V., Fini, M., & Russo, P. (2019) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892814666190102122848 · Cited by 46
Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism
Enoch, M. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.001 · Cited by 46
Genetics of GABAergic signaling in nicotine and alcohol dependence
Cui, W.-Y., Seneviratne, C., Gu, J., & Li, M. D. (2011) · Human Genetics · doi:10.1007/s00439-011-1108-4 · Cited by 43
The α6 nicotinic acetylcholine receptor subunit influences ethanol-induced sedation
Kamens, H. M., Hoft, N. R., Cox, R. J., Miyamoto, J. H., & Ehringer, M. A. (2012) · Alcohol · doi:10.1016/j.alcohol.2012.03.001 · Cited by 43
When Does Choice of Accuracy Measure Alter Imputation Accuracy Assessments?
Ramnarine, S., Zhang, J., Chen, L., Culverhouse, R., Duan, W., Hancock, D. B., Hartz, S. M., Johnson, E. O., Olfson, E., Schwantes-An, T.-H. L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137601 · Cited by 43
Self-citationCannady, R., Rinker, J. A., Nimitvilai, S., Woodward, J. J., & Mulholland, P. J. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2017_90 · Cited by 40
Li, M. D., Ma, J. Z., Payne, T. J., Lou, X.-Y., Zhang, D., Dupont, R. T., & Elston, R. C. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002038 · Cited by 43
Grucza, R. A., Johnson, E. O., Krueger, R. F., Breslau, N., Saccone, N. L., Chen, L., Derringer, J. L., Arpana Agrawal, A., Lynskey, M. T., & Bierut, L. J. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00220.x · Cited by 42
Self-citationŚlimak, M. A., Ables, J. L., Frahm, S., Antolin‐Fontes, B., Santos‐Torres, J., Moretti, M., Gotti, C., & Ibáñez-Tallon, I. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00012 · Cited by 46
Pharmacogenetics of smoking cessation therapy
Kortmann, G. L., Dobler, C. J., Bizarro, L., & Bau, C. H. D. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30978 · Cited by 41
Tyndale, R. F., Zhu, A. Z. X., George, T. P., Cinciripini, P. M., Hawk, L. W., Schnoll, R. A., Swan, G. E., Benowitz, N. L., Heitjan, D. F., & Lerman, C. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128109 · Cited by 43
Self-citationA Human Polymorphism in CHRNA5 Is Linked to Relapse to Nicotine Seeking in Transgenic Rats
Forget, B., Scholze, P., Vives, F. L., Morel, C., Pons, S., Mondoloni, S., Besson, M., Cuttoli, R. D.-D., Hay, Y. A., Tricoire, L., et al. (2018) · Current Biology · doi:10.1016/j.cub.2018.08.044 · Cited by 41
Breitling, L. P., Dahmen, N., Mittelstraß, K., Illig, T., Rujescu, D., Raum, E., Winterer, G., & Brenner, H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.004 · Cited by 43
Clarke, T., Laucht, M., Ridinger, M., Wodarz, N., Rietschel, M., Maier, W., Lathrop, M. G., Lourdusamy, A., Zimmermann, U. S., Desrivières, S., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.247 · Cited by 42
Wang, S., van der Vaart, A. D., Xu, Q., Seneviratne, C., Pomerleau, O. F., Pomerleau, C. S., Payne, T. J., Ma, J. Z., & Li, M. D. (2013) · Human Genetics · doi:10.1007/s00439-013-1398-9 · Cited by 41
Self-citationZuo, L., Zhang, X., Wang, F., Li, C. R., Lu, L., Ye, L., Zhang, H., Krystal, J. H., Deng, H., & Luο, X. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12032 · Cited by 42
Haller, G., Kapoor, M., Budde, J., Xuei, X., Edenberg, H. J., Nürnberger, J. I., Kramer, J., Brooks, A., Tischfield, J. A., Almasy, L. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt463 · Cited by 41
Self-citationPost‐GWAS in Psychiatric Genetics: A Developmental Perspective on the “Other” Next Steps
Dick, D. M., Barr, P. B., Cho, S. B., Cooke, M. E., Kuo, S. I., Lewis, T. J., Neale, Z. E., Salvatore, J. E., Savage, J. E., & Su, J. (2017) · Genes Brain & Behavior · doi:10.1111/gbb.12447 · Cited by 43
Accordini, S., Calciano, L., Johannessen, A., Benediktsdóttir, B., Bertelsen, R. J., Bråbäck, L., Dharmage, S. C., Forsberg, B., Real, F. G., Holloway, J. W., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.02791-2020 · Cited by 42
Stoker, A. K., Olivier, B., & Markou, A. (2012) · Behavior Genetics · doi:10.1007/s10519-011-9511-0 · Cited by 40
New Molecular Insights in Tobacco-Induced Lung Cancer
Tonini, G., D’Onofrio, L., Dell’Aquila, E., & Pezzuto, A. (2013) · Future Oncology · doi:10.2217/fon.13.32 · Cited by 40
P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case–control studies
Dai, S., Mao, C., Jiang, L., Wang, G., & Cheng, H. (2009) · Human Genetics · doi:10.1007/s00439-009-0664-3 · Cited by 40
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes
Gold, A. B., & Lerman, C. E. (2012) · Human Genetics · doi:10.1007/s00439-012-1143-9 · Cited by 41
Chen, L.-S., Baker, T. B., Jorenby, D. E., Piper, M. E., Saccone, N. L., Johnson, E. O., Breslau, N., Hatsukami, D. K., Carney, R. M., & Bierut, L. J. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.06.022 · Cited by 42
Self-citationThe Genetics, Neurogenetics and Pharmacogenetics of Addiction
Demers, C. H., Bogdan, R., & Arpana Agrawal, A. (2014) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-013-0004-8 · Cited by 41
Admixture mapping of lung cancer in 1812 African-Americans
Schwartz, A. G., Wenzlaff, A. S., Bock, C. H., Ruterbusch, J. J., Chen, W., Coté, M. L., Artis, A. S., Dyke, A. L. V., Land, S. J., Harris, C. C., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq252 · Cited by 40
Nicotinic acetylcholine receptors and predisposition to lung cancer
Tournier, J., & Birembaut, P. L. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283412ea1 · Cited by 40
New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice
Bağdaş, D., Alkhlaif, Y., Jackson, A. B., Carroll, F. I., Ditre, J. W., & Damaj, M. I. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.025 · Cited by 42
Association of CHRN genes with “dizziness” to tobacco
Ehringer, M. A., McQueen, M. B., Hoft, N. R., Saccone, N. L., Stitzel, J. A., Wang, J. C. C., & Bierut, L. J. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31027 · Cited by 41
Self-citationPiasecki, T. M., Piper, M. E., & Baker, T. B. (2010) · Journal of Abnormal Psychology · doi:10.1037/a0020235 · Cited by 40
A glimpse into the future – Personalized medicine for smoking cessation
Bierut, L. J., Johnson, E. O., & Saccone, N. L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.009 · Cited by 41
Self-citationZhou, H., Yang, J., Li, D., Xiao, J., Wang, B., Wang, L., Ma, C., Xu, S., Ou, X., & Feng, Y. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.104 · Cited by 38
MacNicol, B. J. (2016) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-016-0771-2 · Cited by 52
Fantuzzo, J. A., Mirabella, V. R., Hamod, A., Hart, R. P., Zahn, J. D., & Pang, Z. P. (2017) · eNeuro · doi:10.1523/eneuro.0219-17.2017 · Cited by 39
O’Brien, T., Jia, P., Caporaso, N. E., Landi, M. T., & Zhao, Z. (2018) · Genome Medicine · doi:10.1186/s13073-018-0522-9 · Cited by 39
Clarke, T., Crist, R. C., Kampman, K. M., Dackis, C. A., Pettinati, H. M., O’Brien, C. P., Oslin, D. W., Ferraro, T. N., Lohoff, F. W., & Berrettini, W. H. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.018 · Cited by 40
Ito, H. M., McKay, J., Hosono, S., Hida, T., Yatabe, Y., Mitsudomi, T., Brennan, P., Tanaka, H., & Matsuo, K. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182475028 · Cited by 37
A Review of Genome-Wide Association Studies of Stimulant and Opioid Use Disorders
Jensen, K. P. (2016) · Complex Psychiatry · doi:10.1159/000444755 · Cited by 38
Bhalala, O. G., Nath, A. P., Inouye, M., & Sibley, C. R. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007607 · Cited by 38
Genome-wide Association Studies of Cancer Predisposition
Stadler, Z. K., Vijai, J., Thom, P., Kirchhoff, T., Hansen, N. A. L., Kauff, N. D., Robson, M. E., & Offit, K. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.06.009 · Cited by 40
Chromosome 15q25 (CHRNA3-CHRNA5) Variation Impacts Indirectly on Lung Cancer Risk
Wang, Y., Broderick, P., Matakidou, A., Eisen, T., & Houlston, R. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019085 · Cited by 38
Kar, S., Tyrer, J. P., Li, Q., Lawrenson, K., Aben, K. K. H., Anton‐Culver, H., Antonenkova, N., Chenevix‐Trench, G., Study, O. B. O. T. A. C., and on behalf of the Australian Ovarian Cancer Study Group, et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1270 · Cited by 38
Distinct Loci in the CHRNA5/CHRNA3/CHRNB4 Gene Cluster Are Associated With Onset of Regular Smoking
Stephens, S. H., Hartz, S. M., Hoft, N. R., Saccone, N. L., Corley, R., Hewitt, J. K., Hopfer, C. J., Breslau, N., Coon, H. H., Chen, X., et al. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21760 · Cited by 41
Self-citationAgrawal, A., Freedman, N., Cheng, Y.-C., Lin, P., Shaffer, J., Sun, Q., Taylor, K. C., Yaspan, B., Cole, J., Cornelis, M. C., et al. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.015545 · Cited by 42
Self-citationYang, J., & Li, M. D. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.67 · Cited by 37
Development of Novel Pharmacotherapeutics for Tobacco Dependence: Progress and Future Directions
Harmey, D., Griffin, P. R., & Kenny, P. J. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts201 · Cited by 37
Tobacco use disorder and treatment: new challenges and opportunities
Ziedonis, D. M., Das, S., & Larkin, C. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/dziedonis · Cited by 36
Nordestgaard, A. T. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02650-9 · Cited by 36
Metadata
- Authors
- Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A. F., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O., Swan, G. E., Goate, A. M., Rutter, J., Bertelsen, S., Fox, L., Fugman, D., Martin, N. G., Montgomery, G. W., Wang, J. C., Ballinger, D. G., Rice, J. P., & Bierut, L. J.
- Affiliations
- Washington University in St. Louis (US)
- Pennsylvania State University (US)
- Perlegen (United States) (US)
- Michigan State University (US)
- RTI International (US)
- University of Minnesota (US)
- University of Michigan (US)
- SRI International (US)
- National Institute on Drug Abuse (US)
- Rutgers, The State University of New Jersey (US)
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Saccone, Scott F.
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-11-29
- Volume
- 16
- Issue
- 1
- Pages
- 36-49
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2270437
- OpenAlex
- W2118320202
- Cited by
- 850
- References
- 48
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 12 · 2023: 20 · 2022: 16 · 2021: 24 · 2020: 65 · 2019: 37 · 2018: 35 · 2017: 35 · 2016: 54 · 2015: 51 · 2014: 48 · 2013: 58 · 2012: 86
- FWCI
- 31.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute on Drug Abuse (R56DA012854, DA12854, DA015129, N01DA07079, K01DA015129, R01DA012854)
- National Cancer Institute (CA89392, P01CA089392)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- nicotine dependence, CHRNA5, single nucleotide polymorphisms, genetic association, genetic susceptibility loci, recessive inheritance, KCNJ6, GABRA4, smoking, Fagerström Test for Nicotine Dependence
- MeSH terms
- Adult, Aged, Aged, 80 and over, Chromosomes, Human, Pair 8, Female, Genetic Markers, Genotype, Humans, Male, Middle Aged, Receptors, Nicotinic, Tobacco Use Disorder, Genetic Variation, Cluster Analysis, Case-Control Studies, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
